Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Koru Medical Systems › Director received an award of 3,472 KRMD shares
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Mar 31, 2026
Reporting period Not applicable
Filed with the SEC Apr 6, 2026 Director Indirect holding Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001161697-26-000088
Filed / recorded Apr 6, 2026, 8:07 PM UTC
Added to OQRO Oct 8, 2026, 1:45 AM UTC
Data quality Verified: identifiers matched exactly
Issuer KORU Medical Systems, Inc.
Reporting person Joseph M. Jr. Manko
Relationship Director, 10% owner
Table Non-derivative (Table I)
Transaction date Mar 31, 2026
Acquired / disposed Acquired (A)
Shares owned after 5,065,970
Ownership form Indirect — By Horton Capital Partners Fund, LP
Footnotes from the filing See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2).
Around the same time Insider filing
Traded Apr 1 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 1 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 1 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Feb 5, 2026 Company filing · Form 8-K · Bylaws or charter Changed its bylaws, charter or fiscal year Mar 12, 2026 Company filing · Form 8-K · Results Reported its results Mar 12, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “Linda Tharby, President and Chief Executive Officer of KORU Medical Systems, Inc. (the “Company”), has announced her retirement as Chief Executive Officer effective June 30, 2026 (the “Transition Date”).” Mar 30, 2026 Company filing · Form 8-K · Material agreement, New debt Signed an important agreement, and took on new debt or obligations What came next May 6, 2026 Company filing · Form 8-K · Results Reported its results May 14, 2026 Insider · 2 people Insiders: 3 purchases (~$41K) May 15, 2026 Insider · 3 insiders in a week, 7th time since 2011 CEO purchased ~$4.7K of KRMD shares in the open market May 18, 2026 Insider · 4 insiders in a week, 2nd time since 2011 Officer purchased ~$20K of KRMD shares in the open market
